Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 18, 2023

SELL
$321.55 - $374.67 $11,254 - $13,113
-35 Reduced 3.78%
892 $0
Q3 2022

Oct 11, 2022

SELL
$296.48 - $337.87 $11,266 - $12,839
-38 Reduced 3.94%
927 $300,000
Q2 2022

Jul 14, 2022

SELL
$278.73 - $327.27 $243,331 - $285,706
-873 Reduced 47.5%
965 $313,000
Q1 2022

Jul 14, 2022

SELL
$234.69 - $291.66 $23,469 - $29,166
-100 Reduced 5.16%
1,838 $526,000
Q4 2021

Jan 19, 2022

SELL
$224.85 - $279.04 $22,485 - $27,904
-100 Reduced 4.91%
1,938 $535,000
Q3 2021

Oct 15, 2021

SELL
$221.6 - $272.71 $398,880 - $490,877
-1,800 Reduced 46.9%
2,038 $471,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $36,110 - $46,708
200 Added 5.5%
3,838 $1.03 Million
Q1 2021

Apr 15, 2021

BUY
$164.32 - $212.72 $82,160 - $106,360
500 Added 15.93%
3,638 $675,000
Q4 2020

Jan 25, 2021

SELL
$130.46 - $172.63 $128,764 - $170,385
-987 Reduced 23.93%
3,138 $530,000
Q3 2020

Oct 15, 2020

BUY
$146.22 - $169.13 $29,244 - $33,826
200 Added 5.1%
4,125 $611,000
Q2 2020

Jul 28, 2020

SELL
$136.42 - $164.18 $37,515 - $45,149
-275 Reduced 6.55%
3,925 $644,000
Q1 2020

Apr 21, 2020

SELL
$119.05 - $147.35 $11,905 - $14,735
-100 Reduced 2.33%
4,200 $583,000
Q3 2019

Oct 10, 2019

BUY
$106.79 - $116.16 $32,037 - $34,848
300 Added 7.5%
4,300 $481,000
Q2 2019

Jul 16, 2019

BUY
$110.79 - $129.32 $44,316 - $51,728
400 Added 11.11%
4,000 $443,000
Q1 2019

Apr 09, 2019

BUY
$111.31 - $131.02 $22,262 - $26,204
200 Added 5.88%
3,600 $467,000
Q4 2018

Jan 17, 2019

SELL
$105.9 - $118.64 $148,260 - $166,096
-1,400 Reduced 29.17%
3,400 $393,000
Q3 2018

Oct 03, 2018

SELL
$85.86 - $107.31 $17,172 - $21,462
-200 Reduced 4.0%
4,800 $515,000
Q1 2018

Apr 25, 2018

SELL
$74.21 - $87.6 $81,631 - $96,360
-1,100 Reduced 18.03%
5,000 $387,000
Q4 2017

Jan 22, 2018

BUY
$81.94 - $87.89 $24,008 - $25,751
293 Added 5.05%
6,100 $515,000
Q3 2017

Oct 18, 2017

BUY
$77.07 - $85.54 $447,545 - $496,730
5,807
5,807 $497,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Juncture Wealth Strategies, LLC Portfolio

Follow Juncture Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Juncture Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Juncture Wealth Strategies, LLC with notifications on news.